Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

M. De Lena,Rodryg Ramlau,Olfred Hansen,Lis Wagner,S. Barni,V. Alberola,Rm Huber,M. Mitrovic,J. Gasmi,J.-C. Pouget

Phase II of oral vinorelbine (NVB oral) in combination with Cisplatin (P) followed by NVB oral single agent as consolidation therapy in advanced non small-cell lung cancer (NSCLC): A Patient's Benefit Analysis

2004

M. De Lena
Rodryg Ramlau
Olfred Hansen
Lis Wagner
S. Barni
V. Alberola
Rm Huber
M. Mitrovic
J. Gasmi
J.-C. Pouget

7338 Background: The goals of chemotherapy in advanced NSCLC are to improve survival and to palliate symptoms.This multinational phase II trial was designed to evaluate a new schedule of NVB oral i...

Keywords:

non-small cell lung cancer (NSCLC)
Vinorelbine
Cisplatin
Oncology
Consolidation therapy
Internal medicine
Medicine
single agent
Chemotherapy
benefit analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations